LGC is to extend its hair drug analysis services in Europe, following an agreement to market a hair test from drug testing company, Psychemedics.
LGC is to extend its hair drug analysis services in Europe, following an agreement to market a hair test from drug testing company, Psychemedics. According to the companies, thousands of corporate clients rely on the hair analysis test and the company’s clients include the New York City Police Department, Chicago Police Department, San Francisco Police Department and many others.
“With this agreement,” said Raymond C. Kubacki, chairman and CEO of Psychemedics, “we hope to capitalize on the rapidly developing growth opportunities in the UK and Europe, and help companies establish and maintain a drug free workplace.”
LGC division, LGC Forensics, works to discover, analyse and present reliable forensic evidence on behalf of law enforcement agencies, legal professionals and private individuals. Hair drug testing is among the range of services on offer from LGC Forensics and is a vital tool in identifying drugs of abuse and drug users. Steve Allen, managing director of LGC Forensics, described the test as an “important tool that expands our current drug testing services to our European clients.”
For more information on the companies visit www.lgc.co.uk and www.drugtestwithhair.com
This story originally appeared in The Column. Click here to view that issue.
Best of the Week: What’s New in MS, 2024 Young Chemist Award Winner
March 22nd 2024This week, LCGC International published a variety of articles on the hottest topics in chromatography and beyond. Below, we’ve highlighted some of the most popular articles, according to our readers. Happy reading!
Using Multidimensional GC Coupled to TOF-MS For the Detection of Tuberculosis-Associated Compounds
March 22nd 2024This study explores the feasibility of using human skin volatile organic compounds (VOCs) analyzed through comprehensive gas chromatography–time of flight–mass spectrometry (GCxGC-TOF-MS) and chemometric techniques, to potentially serve as biomarkers for tuberculosis diagnosis.